Lai Wang

Senior Vice President & Head of Global Research, Clinical Operation & Biometrics & Asia Pacific Clinical Development at BeiGene Ltd.

Lai Wang

Lai Wang

Senior Vice President & Head of Global Research, Clinical Operation & Biometrics & Asia Pacific Clinical Development at BeiGene Ltd.

Biography

Lai Wang, Ph.D., is our Senior Vice President, Head of Global Research, Clinical Operation & Biometrics and APAC Clinical Development. Dr. Wang joined BeiGene in the early days of the company, 2011. His role has changed over the years within the organization, initially heading the biomarker and in vivo pharmacology groups. In 2013, he supported the clinical programs in the role of clinical biomarkers and translational research. In 2016, he was appointed as the head of China development, responsible for the clinical development in Asian-pacific region. Prior to joining BeiGene, Dr. Wang was the director of research at Joyant Pharmaceuticals, a biotech company based in Dallas, Texas. Dr. Wang received his B.S. from Fudan University and Ph.D. from University of Texas Health Science Center at San Antonio, and had post-doc training with Dr. Xiaodong Wang at Howard Hughes Medical Institute. Dr. Wang had over 20 years of experience in oncology field and over 10 years of experience in pharmaceutical industry on both research and development.

Overview
RelSci Relationships

933

Relationships
View Relationship Details
RelSci Relationships are individuals Lai Wang likely has professional access to. A relationship does not necessarily indicate a personal connection.
John V. Oyler

Co-Founder at BeiGene Ltd.

Relationship likelihood: Strong

Xiaodong Wang

Co-Founder at BeiGene Ltd.

Relationship likelihood: Strong

Steven Young

Acting Head of Medicinal Chemistry at BeiGene Ltd.

Relationship likelihood: Strong

Wendy Yan

Senior Vice President, Global Head of Regulatory Affairs at BeiGene Ltd.

Relationship likelihood: Strong

Howard Liang

Chief Financial Officer & Chief Strategy Officer at BeiGene Ltd.

Relationship likelihood: Strong

Kang Li

Head of Biologics at BeiGene (Beijing) Co., Ltd.

Relationship likelihood: Strong

Lusong Luo

Head of Discovery Biology at BeiGene (Beijing) Co., Ltd.

Relationship likelihood: Strong

Zhiwei Wang

Research Head of Chemistry at BeiGene (Beijing) Co., Ltd.

Relationship likelihood: Strong

Min Wei

Head of Molecular Sciences at BeiGene (Beijing) Co., Ltd.

Relationship likelihood: Strong

Scott Samuels

Secretary, General Counsel & Senior Vice President at BeiGene Ltd.

Relationship likelihood: Strong

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
In The News
ENP Newswire
May 27, 2020
-Hutchison China MediTech Limited - Chi-Med and BeiGene Enter into Clinical Collaboration to Evaluate Combinations of Surufatinib and Fruquintinib with Tislelizumab
Business Wire
April 1, 2020
Zymeworks Announces First Patient Dosed in Phase 1b/2 Trial of ZW25 in First-Line HER2-Positive Breast Cancer and Gastroesophageal Adenocarcinoma Conducted by BeiGene
ENP Newswire
August 16, 2018
-BeiGene Initiates New Phase 3 Trial of Anti-PD-1 Antibody Tislelizumab Combined with Chemotherapy
PR Newswire
August 9, 2018
BeiGene Initiates New Phase 3 Trial of Anti-PD-1 Antibody Tislelizumab Combined with Chemotherapy as First-line Treatment for Patients with Advanced Squamous Non-Small Cell Lung Cancer in China
GlobeNewswire
July 24, 2018
BeiGene Initiates Phase 3 Pivotal Trial of Anti-PD-1 Antibody Tislelizumab Combined with Chemotherapy as First-Line Treatment for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer in China
Trending People
Patrick Vallance
UK doctors seek review of 12-week gap between vaccine doses - Associated Press
Henry L. "Hank" Aaron
Home run king Aaron dies at 86THE QUOTE - South Florida Sun-Sentinel
Charles E. Schumer
February date set for Trump trialPelosi to send article of impeachment to Senate... - South Florida Sun-Sentinel
Jennifer Rene Psaki
Signing orders, urging more helpBiden offers some aid and asks Congress for bigg... - South Florida Sun-Sentinel
Boris Johnson
Rotting fish, lost business and piles of red tape. The reality of Brexit hits Br... - CNN
Trending People
Patrick Vallance
UK doctors seek review of 12-week gap between vaccine doses - Associated Press
Henry L. "Hank" Aaron
Home run king Aaron dies at 86THE QUOTE - South Florida Sun-Sentinel
Charles E. Schumer
February date set for Trump trialPelosi to send article of impeachment to Senate... - South Florida Sun-Sentinel
Jennifer Rene Psaki
Signing orders, urging more helpBiden offers some aid and asks Congress for bigg... - South Florida Sun-Sentinel
Boris Johnson
Rotting fish, lost business and piles of red tape. The reality of Brexit hits Br... - CNN
Paths to Lai Wang
Potential Connections via
Relationship Science
You
Lai Wang
Senior Vice President & Head of Global Research, Clinical Operation & Biometrics & Asia Pacific Clinical Development at BeiGene Ltd.
Career History
Senior Vice President & Head of Global Research, Clinical Operation & Biometrics & Asia Pacific Clinical Development
Current
BeiGene Ltd.

BeiGene Ltd. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. It focuses on Zanubrutinib (BGB-3111), Tislelizumab (BGB-A317), and Pamiparib (BGB-290). The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Beijing, China.

Head of Discovery Biomarkers & in Vivo Pharmacology
Current
BeiGene (Beijing) Co., Ltd.

Part of BeiGene Ltd., BeiGene (Beijing) Co., Ltd. is a Chinese company located in Beijing that develops pharmaceuticals.

Other Affiliations

Lai Wang is affiliated with BeiGene Ltd., BeiGene (Beijing) Co., Ltd.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Lai Wang. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Lai Wang's profile does not indicate a business or promotional relationship of any kind between RelSci and Lai Wang.